Rezultati

eNauka >  Results >  Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
Title: Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
Authors : Cadavid, Diego; ...; Drulovic, Plena; ...; (broj, koautora 22)
Issue Date: 2019
Publication: LANCET NEUROLOGY
ISSN: 1474-4422 Lancet Neurology Search Idenfier
Type: Article
Collation: vol. 18 br. 9 str. 845-856
DOI: 10.1016/S1474-4422(19)30137-1
WoS-ID: 000479136100017
Scopus-ID: 2-s2.0-85070392930
URI: https://enauka.gov.rs/handle/123456789/814023
Project: Biogen
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

171
SCOPUSTM
72
OpenCitations
159
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.